This inventor holds 2 USPTO granted patents. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1995-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1996
Title: Koichi Mishima: Innovator in Protein Detection Technologies
Introduction
Koichi Mishima is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of protein detection, particularly through his innovative methods for identifying specific proteins in biological samples. With a total of 2 patents, his work has implications for various applications in health and research.
Latest Patents
Mishima's latest patents focus on the detection of ARD 1 protein, a mammalian guanine nucleotide binding protein with an ADP-ribosylation. The first patent provides a method for detecting the presence of ARD 1 protein in a sample. This method involves providing labeled or immobilized anti-ARD 1 antibody in a reaction zone, introducing the sample into the reaction zone, and detecting the formation of an immunological complex if ARD 1 protein is present. Additionally, cells, nucleotide and amino acid sequences, and vectors associated with ARD 1 are described in the patent. The second patent mirrors the first, emphasizing the same innovative approach to protein detection.
Career Highlights
Mishima works for the United States of America as Represented by the Department of Health. His role in this esteemed organization allows him to contribute to advancements in health-related technologies and research.
Collaborations
Some of his notable coworkers include Joel Moss and Maria S Nightingale. Their collaborative efforts enhance the research and development of innovative solutions in the field of protein detection.
Conclusion
Koichi Mishima's contributions to the field of protein detection through his patents demonstrate his commitment to advancing scientific knowledge and health technologies. His work continues to influence research and applications in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
